CLINICAL_TRIALS
trial_result
· 2013-10-23
Clinical Trial Update: A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children [Phase 3]
Summary
A Phase 3 study comparing two doses of MAP0010 to placebo in asthmatic children has completed, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2013-10-23